Accessibility settings

This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (730) Non-randomized Protocols and Methods (ehealth) (716) Methods and Feasibility Studies (516) Statistical Methods (31) Immunology, Allergy, Rheumatology (153)

Published on in Vol 15 (2026)

This is a member publication of University of Cambridge (Jisc)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/81415, first published .
Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Evaluation of the Long-Term Safety of Avacopan in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Real World (AvacoStar): Protocol for a Noninterventional Prospective Cohort Study

Authors of this article:

David R W Jayne1 Author Orcid Image ;   Raashid Luqmani2 Author Orcid Image ;   Benjamin Terrier3 Author Orcid Image ;   Achim Obergfell4 Author Orcid Image ;   Charlotte Pollet4 Author Orcid Image ;   Marie Boff5 Author Orcid Image ;   Monica Balcells-Oliver4 Author Orcid Image ;   Bernhard Hellmich6 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

There are no citations yet available for this article according to Crossref .